ECDC is monitoring reports from three countries (France, the United Kingdom and the United States) of cases of invasive meningococcal disease (IMD) associated with travel to the Kingdom of Saudi Arabia (KSA).
The EVD-LabNet is strengthening capacity for early detection and surveillance of (re)emerging viral diseases in the EU/EEA countries and EU Candidate Countries.
This report presents the results of the 11th round of the external quality assessment (EQA-11) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
The Emerging and Vector-borne Diseases (EVD) team of ECDC communicates, consults and cooperates with EVD-Net on surveillance, response, prevention, control and preparedness aspects of EVDs and vectors, with particular focus on country needs and country support possibilities.
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues and deployment of resources and training where necessary.
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues and deployment of resources and training where necessary.